跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LASTIFLUNO 137 MICROGRAMOS/50 MICROGRAMOS/ APLICACIÓN SUSPENSION PARA PULVERIZACION NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LASTIFLUNO 137 MICROGRAMOS/50 MICROGRAMOS/ APLICACIÓN SUSPENSION PARA PULVERIZACION NASAL
Approved
STANDARD
LASTIFLUNO 137 MICROGRAMOS/50 MICROGRAMOS/ APLICACIÓN SUSPENSION PARA PULVERIZACION NASAL
Day Zero Ehf.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 18, 2025
Approval ID
d4b04597a1e1417b
Company
Day Zero Ehf.
Type
Standard
Approval Details
Approval Id
d4b04597a1e1417b
Drug Cima Aemps Name
LASTIFLUNO 137 MICROGRAMOS/50 MICROGRAMOS/ APLICACIÓN SUSPENSION PARA PULVERIZACION NASAL
Register Number
90210
Holder Company Name
Day Zero Ehf.
Marketing Company Name
Day Zero Ehf.
Authorization Date
2025-03-18
Dosage Form
SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose
137 microgramos/50 microgramos
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Day Zero Ehf.
Active Ingredients
AZELASTINA HIDROCLORURO
0,989 mg/g
FLUTICASONA PROPIONATO
0,361 mg/g
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 18, 2025
Approval ID
d4b04597a1e1417b
Type
Standard
Back to CIMA-AEMPS Approvals